The estimated Net Worth of James E. Levine is at least $697 Mille dollars as of 16 September 2022. Mr. Levine owns over 30,000 units of Cidara Therapeutics Inc stock worth over $697,200 and over the last 6 years he sold CDTX stock worth over $0. In addition, he makes $0 as Chief Financial Officer at Cidara Therapeutics Inc.
Sign up
Mr. Levine CDTX stock SEC Form 4 insiders trading
James has made over 4 trades of the Cidara Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 30,000 units of CDTX stock worth $46,800 on 16 September 2022.
The largest trade he's ever made was buying 50,000 units of Cidara Therapeutics Inc stock on 10 November 2020 worth over $100,500. On average, James trades about 11,667 units every 91 days since 2018. As of 16 September 2022 he still owns at least 60,000 units of Cidara Therapeutics Inc stock.
You can see the complete history of Mr. Levine stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
James Levine biography
James E. Levine serves as Chief Financial Officer of the Company. Prior to joining Cidara, Mr. Levine held senior executive and Board roles at two biotechnology companies, Sapphire Energy and Verenium Corporation, both of which were focused on the development, manufacture and sale of products for the human and animal nutrition markets. Previously, Mr. Levine was a managing director in the investment banking division of Goldman Sachs & Co. in both New York and London, where he spent 11 years focused on serving clients in the healthcare and energy industries. Mr. Levine holds a Master of Business Administration degree from the Wharton School of the University of Pennsylvania and a Bachelor of Arts degree in Economics from Brandeis University.
How old is James Levine?
James Levine is 49, he's been the Chief Financial Officer of Cidara Therapeutics Inc since 2018. There are 11 older and 5 younger executives at Cidara Therapeutics Inc. The oldest executive at Cidara Therapeutics Inc is Dr. Kenneth F. Bartizal Ph.D., 70, who is the Chief Devel. Officer.
What's James Levine's mailing address?
James's mailing address filed with the SEC is C/O CARDIFF ONCOLOGY, INC., 11055 FLINTKOTE AVE, SAN DIEGO, CA, 92121.
Insiders trading at Cidara Therapeutics Inc
Over the last 15 years, insiders at Cidara Therapeutics Inc have traded over $256,071 worth of Cidara Therapeutics Inc stock and bought 1,216,676 units worth $9,796,257 . The most active insiders traders include Capital Management, L.P.Ra ..., Target N Vbb Biotech Ag Bio... e Steve Elms. On average, Cidara Therapeutics Inc executives and independent directors trade stock every 52 days with the average trade being worth of $282,598. The most recent stock trade was executed by Jeffrey Stein on 7 June 2024, trading 8,000 units of CDTX stock currently worth $105,680.
What does Cidara Therapeutics Inc do?
cidara is a biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases that are inadequately addressed by current standard of care therapies. our first product candidate is cd101 iv, a potential once-weekly intravenous therapy being developed for the treatment and prevention of systemic fungal infections. our second product candidate, cd101 topical, is a topical formulation of cd101, the first topical application of the enchinocandin class of anti-fungals, for the treatment of vulvovaginal candidiasis, or vvc. in addition, we have developed a proprietary immunotherapy technology platform, cloudbreak™, which we use to create compounds designed to direct a patient’s immune cells to attack and eliminate pathogens that cause infectious disease. we are developing our first cloudbreak development candidate, c001, for the treatment of invasive aspergillosis.
What does Cidara Therapeutics Inc's logo look like?
Complete history of Mr. Levine stock trades at Cidara Therapeutics Inc e Cardiff Oncology
Cidara Therapeutics Inc executives and stock owners
Cidara Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Jeffrey Stein,
President, Chief Executive Officer, Director -
Dr. Jeffrey L. Stein Ph.D.,
Pres, CEO & Exec. Director -
Neil Abdollahian,
Chief Business Officer -
Taylor Sandison,
Chief Medical Officer -
Paul Daruwala,
Chief Operating Officer -
Dr. Taylor Sandison,
Chief Medical Officer -
Daniel Burgess,
Independent Chairman of the Board -
Theodore Schroeder,
Independent Director -
Chrysa Mineo,
Independent Director -
Timothy Franson,
Independent Director -
David Gollaher,
Independent Director -
Robert Uhl,
IR Contact Officer -
Jessica Oien,
General Counsel, Secretary -
James Levine,
Chief Financial Officer -
Dr. Kenneth F. Bartizal Ph.D.,
Chief Devel. Officer -
Allison Lewis CCP, SPHR,
VP of HR -
Shane M. Ward,
Chief Legal Officer & Corp. Sec. -
Christopher A. Kurtz,
Exec. VP of Technical Operations -
Brady Johnson,
Principal Accounting Officer, Controller & VP of Fin. -
Paul Daruwala,
COO & Chief Commercial Officer -
Dr. Preetam Shah M.B.A., Ph.D.,
CFO & Chief Bus. Officer -
Dr. Kevin M. Forrest Ph.D.,
Founder and Chief Strategy Officer -
Robert J Perez,
Director -
Scott M Rocklage,
Director -
Ken Bartizal,
Chief Development Officer -
Matthew Onaitis,
Gnrl Counsel, CFO & Secretary -
Marc Wilson,
Chief Accounting Officer -
Dirk Thye,
Chief Medical Officer -
Kevin Forrest,
COO & CFO -
Laura Tadvalkar,
Director -
Preetam Shah,
CFO & CBO -
Target N Vbb Biotech Ag Bio...,
-
Patrick J Heron,
Director -
Nina S Kjellson,
Director -
Steve Elms,
Director -
Bonnie L Bassler,
Director -
Carin Canale Theakston,
Director -
Leslie Tari,
CHIEF SCIENTIFIC OFFICER -
Brady Johnson,
Vice President, Finance -
Shane Ward,
COO & CLO -
Ryan Spencer,
Director -
James Merson,
Director -
Capital Management, L.P.Ra ...,